Menopausal hormone therapy: assessing associations with breast and colorectal cancers by familial risk.
Saved in:
| Title: | Menopausal hormone therapy: assessing associations with breast and colorectal cancers by familial risk. |
|---|---|
| Authors: | MacInnis RJ; Cancer Epidemiology Division, Cancer Council Victoria, East Melbourne, VIC 3002, Australia.; Centre for Epidemiology and Biostatistics, The University of Melbourne, Parkville, VIC 3053, Australia., Jenkins MA; Centre for Epidemiology and Biostatistics, The University of Melbourne, Parkville, VIC 3053, Australia.; Cancer Research Centre, University of Melbourne, Parkville, VIC 3053, Australia., Milne RL; Cancer Epidemiology Division, Cancer Council Victoria, East Melbourne, VIC 3002, Australia.; Centre for Epidemiology and Biostatistics, The University of Melbourne, Parkville, VIC 3053, Australia.; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC 3800, Australia., John EM; Department of Epidemiology & Population Health, Stanford University School of Medicine, Stanford, CA 94305, United States.; Department of Medicine (Oncology), Stanford University School of Medicine, Stanford, CA 94305, United States.; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA 94305, United States., Daly MB; Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA 19111, United States., Andrulis IL; Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Department of Molecular Genetics, University of Toronto, Toronto, ON M5G 1X5, Canada., Colonna SV; Department of Internal Medicine and Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, United States., Phillips KA; Centre for Epidemiology and Biostatistics, The University of Melbourne, Parkville, VIC 3053, Australia.; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC 3052, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, VIC 3010, Australia., Le Marchand L; Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI 96813, United States., Newcomb PA; Epidemiology Department, University of Washington, Seattle, WA 98195, United States.; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, United States., Phipps AI; Epidemiology Department, University of Washington, Seattle, WA 98195, United States.; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, United States., Schmit SL; Genomic Medicine Institute, Cleveland Clinic, Cleveland, OH 44196, United States.; Population and Cancer Prevention Program, Case Comprehensive Cancer Center, Cleveland, OH 44106, United States., Macrae FA; Department of Colorectal Medicine and Genetics, Royal Melbourne Hospital, VIC 3052, Australia., Buchanan DD; Cancer Research Centre, University of Melbourne, Parkville, VIC 3053, Australia.; Colorectal Oncogenomics Group, Department of Clinical Pathology, The University of Melbourne, Parkville, VIC 3010, Australia.; Genomic Medicine and Family Cancer Clinic, The Royal Melbourne Hospital, Parkville, VIC 3052, Australia., Gallinger S; Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Department of Molecular Genetics, University of Toronto, Toronto, ON M5G 1X5, Canada.; PanCuRx Translational Research Initiative, Ontario Institute for Cancer Research, Toronto, ON M5G 1M1, Canada.; Hepatobiliary/Pancreatic Surgical Oncology Program, University Health Network, Toronto, ON M5G 2C4, Canada., Pai RK; Department of Laboratory Medicine and Pathology, Mayo Clinic, Scottsdale, AZ 85259, United States., Samadder NJ; Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Phoenix, AZ 85259, United States., Giles GG; Cancer Epidemiology Division, Cancer Council Victoria, East Melbourne, VIC 3002, Australia.; Centre for Epidemiology and Biostatistics, The University of Melbourne, Parkville, VIC 3053, Australia.; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC 3800, Australia., Southey MC; Cancer Epidemiology Division, Cancer Council Victoria, East Melbourne, VIC 3002, Australia.; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC 3800, Australia.; Genetic Epidemiology Laboratory, Department of Pathology, The University of Melbourne, Parkville, VIC 3010, Australia., Hopper JL; Centre for Epidemiology and Biostatistics, The University of Melbourne, Parkville, VIC 3053, Australia., Terry MB; Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY 10032, United States.; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY 10032, United States. |
| Corporate Authors: | kConFab Investigators |
| Source: | JNCI cancer spectrum [JNCI Cancer Spectr] 2025 Jan 03; Vol. 9 (1). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 101721827 Publication Model: Print Cited Medium: Internet ISSN: 2515-5091 (Electronic) Linking ISSN: 25155091 NLM ISO Abbreviation: JNCI Cancer Spectr Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2515-5091 |
|---|---|
| DOI: | 10.1093/jncics/pkae121 |
